/
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Fibromyalgia is an emerging landscape with 24 programs across 30 companies. 1 program is in Phase 3.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Analysis
95%
Small molecule
20 of 21 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 21 classified programs, each share of the total. Modality classified for 88% of 24 pipeline programs.
Analysis
279
clinical trials
Clinical Trials
279 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)